You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Position Statement on Prostate Cancer Screening using the Prostate-Specific Antigen (PSA) Test

avr 2017
Type of Content: Guidelines & Advice, Position Statement
Document Status: Current

Guideline Objective

Due to the potential harms of screening, including over-diagnosis and over-treatment, Cancer Care Ontario does not support an organized, population-based screening program for prostate cancer. We will continue to watch for new evidence on prostate cancer screening.

Intended Guideline Users

Healthcare providers across Ontario

pdf download Full Report (PDF) (162.76 Ko)

Guideline-Based Clinical Tools

Questions and Answers about the Prostate Cancer Screening with the Prostate-Specific Antigen Test
Key Messages for Primary Care Providers about Prostate Cancer Screening with the Prostate-Specific Antigen Test
PSA Test Decision Grid